0001127602-21-018908.txt : 20210603
0001127602-21-018908.hdr.sgml : 20210603
20210603142736
ACCESSION NUMBER: 0001127602-21-018908
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwarzentraub Barbara J
CENTRAL INDEX KEY: 0001788466
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39218
FILM NUMBER: 21992114
MAIL ADDRESS:
STREET 1: C/O CONMED CORPORATION
STREET 2: 11311 CONCEPT BOULEVARD
CITY: LARGO
STATE: FL
ZIP: 33773
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONMED Corp
CENTRAL INDEX KEY: 0000816956
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 160977505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11311 CONCEPT BOULEVARD
CITY: LARGO
STATE: FL
ZIP: 33773
BUSINESS PHONE: 727-214-2974
MAIL ADDRESS:
STREET 1: 11311 CONCEPT BOULEVARD
CITY: LARGO
STATE: FL
ZIP: 33773
FORMER COMPANY:
FORMER CONFORMED NAME: CONMED CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-06-01
0000816956
CONMED Corp
CNMD
0001788466
Schwarzentraub Barbara J
C/O CONMED CORPORATION
11311 CONCEPT BOULEVARD
LARGO
FL
33773
1
Common Stock
2021-06-01
4
M
0
1521
0
A
2416
D
Rsus (restricted Stock Units)
0
2021-06-01
4
M
0
1521
0
D
2021-06-01
2030-06-01
Common Stock
1521
0
D
Rsus (restricted Stock Units)
0
2021-06-01
4
A
0
812
0
A
2022-06-01
2031-06-01
Common Stock
812
812
D
Options To Purchase Common Stock
138.45
2021-06-01
4
A
0
865
0
A
2022-06-01
2031-06-01
Common Stock
865
865
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
/s/Sarah M. Oliker for Barbara J. Schwarzentraub by Power of Attorney
2021-06-02